• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of resin perfusion in hepatic failure in vitro and in vivo.体外和体内肝衰竭中树脂灌注的评估。
World J Gastroenterol. 2004 Mar 15;10(6):837-40. doi: 10.3748/wjg.v10.i6.837.
2
[Study on the adsorption of endotoxin and proinflammatory cytokines with HB-H-7 resin in vitro].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Mar;21(3):179-82.
3
[An experimental study of plasma-perfusion with a novel aminated chitosan on liver failure in a canine model].新型胺化壳聚糖血浆灌注对犬肝衰竭模型影响的实验研究
Zhonghua Gan Zang Bing Za Zhi. 2008 Sep;16(9):692-5.
4
In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines.通过吸附剂进行体外血浆灌注和血浆超滤以去除内毒素和细胞因子。
Circ Shock. 1992 Nov;38(3):182-8.
5
Randomized controlled study of plasma exchange combined with molecular adsorbent re-circulating system for the treatment of liver failure complicated with hepatic encephalopathy.血浆置换联合分子吸附再循环系统治疗肝衰竭合并肝性脑病的随机对照研究
Hepatogastroenterology. 2012 Jul-Aug;59(117):1323-6. doi: 10.5754/hge12203.
6
Removal of Bilirubin with a New Adsorbent System: In Vitro Kinetics.新型吸附剂系统清除胆红素:体外动力学。
Blood Purif. 2019;47(1-3):10-15. doi: 10.1159/000492378. Epub 2018 Sep 14.
7
Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure.急性肝衰竭患者血浆置换去除内毒素和细胞因子。
Crit Care Med. 1998 May;26(5):873-6. doi: 10.1097/00003246-199805000-00021.
8
Bilirubin adsorbent column for plasma perfusion.用于血浆灌注的胆红素吸附柱。
Ther Apher. 1998 May;2(2):129-33. doi: 10.1111/j.1744-9987.1998.tb00090.x.
9
New type of artificial liver support system (ALSS) using the photocatalytic effect of titanium oxide.利用二氧化钛光催化作用的新型人工肝支持系统(ALSS)
Dig Dis Sci. 2007 Sep;52(9):2271-5. doi: 10.1007/s10620-006-9701-4. Epub 2007 Apr 12.
10
The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.白蛋白透析过程中细胞因子浓度的降低与慢性肝衰竭急性发作患者的预后相关。
Transplant Proc. 2005 Jul-Aug;37(6):2551-3. doi: 10.1016/j.transproceed.2005.06.040.

引用本文的文献

1
New type of artificial liver support system (ALSS) using the photocatalytic effect of titanium oxide.利用二氧化钛光催化作用的新型人工肝支持系统(ALSS)
Dig Dis Sci. 2007 Sep;52(9):2271-5. doi: 10.1007/s10620-006-9701-4. Epub 2007 Apr 12.
2
The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure.重症监护病房中的分子吸附循环系统(MARS):一种用于肝衰竭患者的抢救治疗方法。
Crit Care. 2006 Feb;10(1):118. doi: 10.1186/cc4825.

本文引用的文献

1
Polymerization of resin composite restorative materials: exposure reciprocity.
Dent Mater. 2003 Sep;19(6):531-41. doi: 10.1016/s0109-5641(02)00101-x.
2
A comparative study of two chelating ion-exchange resins for the removal of chromium(III) from aqueous solution.两种用于从水溶液中去除铬(III)的螯合离子交换树脂的比较研究。
J Hazard Mater. 2003 Jun 27;100(1-3):231-43. doi: 10.1016/s0304-3894(03)00110-9.
3
Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure.肝功能衰竭患者通过MARS透析进行体外解毒的进展。
Curr Med Chem. 2003 Feb;10(4):341-8. doi: 10.2174/0929867033368394.
4
Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review.急性和慢加急性肝衰竭的人工及生物人工支持系统:一项系统评价
JAMA. 2003 Jan 8;289(2):217-22. doi: 10.1001/jama.289.2.217.
5
Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus.多粘菌素B固定化纤维血液灌流联合替考拉宁治疗耐甲氧西林金黄色葡萄球菌败血症
J Hosp Infect. 2003 Jan;53(1):58-63. doi: 10.1053/jhin.2002.1332.
6
Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients.
Ther Apher. 2002 Dec;6(6):419-24. doi: 10.1046/j.1526-0968.2002.00464.x.
7
Advanced technology for extracorporeal liver support system devices.
Int J Artif Organs. 2002 Oct;25(10):939-49. doi: 10.1177/039139880202501008.
8
Review of methods to remove protein-bound substances in liver failure.肝衰竭中去除蛋白质结合物质的方法综述
Int J Artif Organs. 2002 Oct;25(10):911-7. doi: 10.1177/039139880202501003.
9
Literature overview on artificial liver support in fulminant hepatic failure: a methodological approach.暴发性肝衰竭人工肝支持的文献综述:一种方法学途径
Int J Artif Organs. 2002 Oct;25(10):903-10. doi: 10.1177/039139880202501002.
10
Intestinal endotoxemia as a pathogenetic mechanism in liver failure.肠道内毒素血症作为肝衰竭的发病机制
World J Gastroenterol. 2002 Dec;8(6):961-5. doi: 10.3748/wjg.v8.i6.961.

体外和体内肝衰竭中树脂灌注的评估。

Assessment of resin perfusion in hepatic failure in vitro and in vivo.

作者信息

Wang Ying-Jie, Wang Ze-Wen, Luo Bing-Wei, Liu Hong-Ling, Wen Hong-Wei

机构信息

Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.

出版信息

World J Gastroenterol. 2004 Mar 15;10(6):837-40. doi: 10.3748/wjg.v10.i6.837.

DOI:10.3748/wjg.v10.i6.837
PMID:15040028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4727023/
Abstract

AIM

To observe the adsorbent effect of resin on endotoxin, cytokine, bilirubin in plasma of patients with hepatic failure and to determine the resin perfusion as an artificial liver support system in the treatment of hepatic failure.

METHODS

One thousand milliliters of discarded plasma was collected from each of 6 severe hepatitis patients treated with plasma exchange. The plasma was passed through a resin perfusion equipment for 1-2 h via extracorporeal circulation, and then absorbent indicators of transaminase, bilirubin, blood ammonia, endotoxin and cytokines were examined. In the meantime, study of in vivo resin plasma perfusion was performed on 7 severe hepatitis patients to compare the changes of endotoxin and cytokines in blood before and after perfusion.

RESULTS

The levels of total bilirubin, endotoxin, interleukin 1beta and TNF-alpha in plasma were significantly decreased after in vitro resin plasma perfusion. The levels of interleukin 1beta, TNF-alpha and endotoxin in blood were also evidently declined after in vivo resin plasma perfusion. Nevertheless, no obvious changes in IL-6, creatinine (Cr) and urea nitrogen (UN), blood ammonia and electrolytes were found both in vitro and in vivo.

CONCLUSION

Bilirubin, endotoxin and cytokines in plasma of patients with hepatic failure can be effectively adsorbed by resin in vitro. Most cytokines and endotoxin in plasma can also be effectively removed by resin in vivo. It demonstrates that resin perfusion may have good treatment efficacy on hepatic failure and can be expected to slow down the progression of hepatic failure.

摘要

目的

观察树脂对肝衰竭患者血浆中内毒素、细胞因子、胆红素的吸附作用,确定树脂灌注作为人工肝支持系统治疗肝衰竭的效果。

方法

从6例接受血浆置换治疗的重型肝炎患者中,每人采集1000毫升废弃血浆。血浆通过体外循环经树脂灌注装置1 - 2小时,然后检测转氨酶、胆红素、血氨、内毒素及细胞因子的吸附指标。同时,对7例重型肝炎患者进行体内树脂血浆灌注研究,比较灌注前后血液中内毒素及细胞因子的变化。

结果

体外树脂血浆灌注后,血浆中总胆红素、内毒素、白细胞介素1β及肿瘤坏死因子-α水平显著降低。体内树脂血浆灌注后,血液中白细胞介素1β、肿瘤坏死因子-α及内毒素水平也明显下降。然而,体外及体内实验中白细胞介素-6、肌酐(Cr)、尿素氮(UN)、血氨及电解质均未发现明显变化。

结论

树脂可有效吸附体外肝衰竭患者血浆中的胆红素、内毒素及细胞因子。树脂也可有效去除体内血浆中的多数细胞因子及内毒素。表明树脂灌注对肝衰竭可能具有良好的治疗效果,有望减缓肝衰竭的进展。